Aptose Biosciences Inc - Company Profile
Powered by 
All the data and insights you need on Aptose Biosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Aptose Biosciences Inc Strategy Report
- Understand Aptose Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Aptose Biosciences Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| TWI821174B | Grant | Methods for treating patients with hematolgic malignancies | A61K31/4178; A61P35/02; C07D403/04 | November 11, 2023 |
| AU2022252696A1 | Application | Methods for treating patients with hematologic malignancies | A61K31/4178; A61P35/02; C07D403/04 | November 03, 2022 |
| EP3886840A4 | Search Report | Kombinationstherapie mit 2,3-dihydro-isoindol-1-on-verbindungen und verfahren zur behandlung von patienten mit verschiedenen mutationen | A61K2300/00; A61K31/4178; A61K31/495; A61K31/496; A61K31/5377; A61K31/635; A61K45/06; A61K9/20; A61K9/2004; A61P35/02 | August 24, 2022 |
| AU2018225539B2 | Grant | Methods for treating patients with hematologic malignancies | A61K31/4178; A61P35/02; C07D403/04 | July 14, 2022 |
| US11279703B2 | Grant | Fused pyrimidine compounds as brd4 and jak2 dual inhibitors and methods for use thereof | A61K31/498; A61K31/519; A61K45/06; A61P35/00; A61P35/02; C07D401/12; C07D403/12; C07D403/14; C07D405/10; C07D417/10; C07D471/04; C07D471/18; C07D487/04; C07D491/048; C07D495/04; C07D495/14; C07D519/00 | March 22, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer